Cargando…

Comment on “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”

Detalles Bibliográficos
Autores principales:	Uzunparmak, Burak, Sahin, Ibrahim H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189067/ https://www.ncbi.nlm.nih.gov/pubmed/30297772 http://dx.doi.org/10.1038/s41416-018-0279-3

Ejemplares similares

Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
por: Roseweir, Antonia K., et al.
Publicado: (2018)

ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
por: Roseweir, Antonia K., et al.
Publicado: (2018)

Comment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”
por: Milano, Gérard, et al.
Publicado: (2020)

Pancreatic cancer microenvironment: a current dilemma
por: Uzunparmak, Burak, et al.
Publicado: (2019)

The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses
por: Chen, Yungchang, et al.
Publicado: (2023)

P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b
por: Naffa, Randa, et al.
Publicado: (2020)

Combination drug development in BRAF mutant colorectal cancer
por: Lam, Michael, et al.
Publicado: (2018)

Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer
por: Pickles, Oliver J., et al.
Publicado: (2020)

PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation
por: Marranci, Andrea, et al.
Publicado: (2023)

Comment on: α-smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
por: Sahin, I H, et al.
Publicado: (2015)

Aluminum Nanoparticles Induce ERK and p38MAPK Activation in Rat Brain
por: Kwon, Jung-Taek, et al.
Publicado: (2013)

Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013)

Leptin Inhibits Glucose Intestinal Absorption via PKC, p38MAPK, PI3K and MEK/ERK
por: El-Zein, Ola, et al.
Publicado: (2013)

Protease Allergens Induce the Expression of IL-25 via Erk and p38 MAPK Pathway
por: Yu, Hak Sun, et al.
Publicado: (2010)

A Specific Oligodeoxynucleotide Promotes the Differentiation of Osteoblasts via ERK and p38 MAPK Pathways
por: Hou, Xu, et al.
Publicado: (2012)

P38/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL-17
por: Tan, Qi, et al.
Publicado: (2017)

Bakuchiol Suppresses Inflammatory Responses Via the Downregulation of the p38 MAPK/ERK Signaling Pathway
por: Lim, Hye-Sun, et al.
Publicado: (2019)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019)

Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways
por: Xie, Jingyi, et al.
Publicado: (2023)

Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways
por: Wanachewin, Orawan, et al.
Publicado: (2012)

Effect of Repeated Electroacupuncture Intervention on Hippocampal ERK and p38MAPK Signaling in Neuropathic Pain Rats
por: Wang, Jun-ying, et al.
Publicado: (2015)

Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
por: Barreto, Rafael, et al.
Publicado: (2016)

Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK
por: Wong, Siew Ying, et al.
Publicado: (2016)

BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS
por: Park, Jong-Whi, et al.
Publicado: (2021)

The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments
por: Pranteda, Angelina, et al.
Publicado: (2020)

Emerging treatment options for BRAF-mutant colorectal cancer
por: Ursem, Carling, et al.
Publicado: (2018)

Molecular targeted therapy of BRAF-mutant colorectal cancer
por: Ducreux, Michel, et al.
Publicado: (2019)

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016)

Clinical responses to ERK inhibition in BRAF(V600E)-mutant colorectal cancer predicted using a computational model
por: Kirouac, Daniel C., et al.
Publicado: (2017)

Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways
por: Ho, Kenneth K. Y., et al.
Publicado: (2023)

Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015)

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells
por: Pietrobono, Silvia, et al.
Publicado: (2022)

Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
por: Nakamura, Koichi, et al.
Publicado: (2023)

Quinpirole Increases Melatonin-Augmented Pentobarbital Sleep via Cortical ERK, p38 MAPK, and PKC in Mice
por: Hong, Sa-Ik, et al.
Publicado: (2016)

Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling
por: Gartz, Melanie, et al.
Publicado: (2018)

A sestrin-dependent Erk/Jnk/p38 MAPK activation complex inhibits immunity during ageing
por: Lanna, Alessio, et al.
Publicado: (2017)

Glabridin attenuates lipopolysaccharide-induced acute lung injury by inhibiting p38MAPK/ERK signaling pathway
por: Zhang, Li-peng, et al.
Publicado: (2016)

Floridoside Exhibits Antioxidant Properties by Activating HO-1 Expression via p38/ERK MAPK Pathway
por: Niu, Tingting, et al.
Publicado: (2020)

Deoxynivalenol Induces Inflammation in IPEC-J2 Cells by Activating P38 Mapk And Erk1/2
por: Zhang, Hua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jou4jhov17kof9gbqusbsjn0fh